Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

CT features of HER2-mutant lung adenocarcinomas.

Sawan P, Plodkowski AJ, Li AE, Li BT, Drilon A, Capanu M, Ginsberg MS.

Clin Imaging. 2018 Sep - Oct;51:279-283. doi: 10.1016/j.clinimag.2018.05.028. Epub 2018 Jun 7. Review.

2.

From genotype to phenotype: Are there imaging characteristics associated with lung adenocarcinomas harboring RET and ROS1 rearrangements?

Plodkowski AJ, Drilon A, Halpenny DF, O'Driscoll D, Blair D, Litvak AM, Zheng J, Moskowitz CS, Ginsberg MS.

Lung Cancer. 2015 Nov;90(2):321-5. doi: 10.1016/j.lungcan.2015.09.018. Epub 2015 Sep 21.

3.

EGFR L858R mutation is associated with lung adenocarcinoma patients with dominant ground-glass opacity.

Yang Y, Yang Y, Zhou X, Song X, Liu M, He W, Wang H, Wu C, Fei K, Jiang G.

Lung Cancer. 2015 Mar;87(3):272-7. doi: 10.1016/j.lungcan.2014.12.016. Epub 2015 Jan 5.

PMID:
25582278
4.

Computed tomography and clinical features associated with epidermal growth factor receptor mutation status in stage I/II lung adenocarcinoma.

Zou J, Lv T, Zhu S, Lu Z, Shen Q, Xia L, Wu J, Song Y, Liu H.

Thorac Cancer. 2017 May;8(3):260-270. doi: 10.1111/1759-7714.12436. Epub 2017 Apr 6.

5.

Metabolic phenotype of stage IV lung adenocarcinoma: relationship with epidermal growth factor receptor mutation.

Lee EY, Khong PL, Lee VH, Qian W, Yu X, Wong MP.

Clin Nucl Med. 2015 Mar;40(3):e190-5. doi: 10.1097/RLU.0000000000000684.

PMID:
25608155
6.

EGFR mutation status in primary lung adenocarcinomas and corresponding metastatic lesions: discordance in pleural metastases.

Han HS, Eom DW, Kim JH, Kim KH, Shin HM, An JY, Lee KM, Choe KH, Lee KH, Kim ST, Koo JH, Lee HC, Lee OJ.

Clin Lung Cancer. 2011 Nov;12(6):380-6. doi: 10.1016/j.cllc.2011.02.006. Epub 2011 May 20.

PMID:
21729655
7.

Imaging Characteristics of Driver Mutations in EGFR, KRAS, and ALK among Treatment-Naïve Patients with Advanced Lung Adenocarcinoma.

Park J, Kobayashi Y, Urayama KY, Yamaura H, Yatabe Y, Hida T.

PLoS One. 2016 Aug 12;11(8):e0161081. doi: 10.1371/journal.pone.0161081. eCollection 2016.

8.

Correlation between computed tomography findings and epidermal growth factor receptor and KRAS gene mutations in patients with pulmonary adenocarcinoma.

Sugano M, Shimizu K, Nakano T, Kakegawa S, Miyamae Y, Kaira K, Araki T, Kamiyoshihara M, Kawashima O, Takeyoshi I.

Oncol Rep. 2011 Nov;26(5):1205-11. doi: 10.3892/or.2011.1412. Epub 2011 Aug 2.

PMID:
21811765
9.

Radiogenomic correlation in lung adenocarcinoma with epidermal growth factor receptor mutations: Imaging features and histological subtypes.

Hong SJ, Kim TJ, Choi YW, Park JS, Chung JH, Lee KW.

Eur Radiol. 2016 Oct;26(10):3660-8. doi: 10.1007/s00330-015-4196-z. Epub 2016 Jan 19.

PMID:
26787602
10.

CT Features Associated with Epidermal Growth Factor Receptor Mutation Status in Patients with Lung Adenocarcinoma.

Liu Y, Kim J, Qu F, Liu S, Wang H, Balagurunathan Y, Ye Z, Gillies RJ.

Radiology. 2016 Jul;280(1):271-80. doi: 10.1148/radiol.2016151455. Epub 2016 Mar 3.

11.

EGFR and KRAS mutations in lung carcinomas in the Dutch population: increased EGFR mutation frequency in malignant pleural effusion of lung adenocarcinoma.

Smits AJ, Kummer JA, Hinrichs JW, Herder GJ, Scheidel-Jacobse KC, Jiwa NM, Ruijter TE, Nooijen PT, Looijen-Salamon MG, Ligtenberg MJ, Thunnissen FB, Heideman DA, de Weger RA, Vink A.

Cell Oncol (Dordr). 2012 Jun;35(3):189-96. doi: 10.1007/s13402-012-0078-4. Epub 2012 Apr 12.

12.

Association Between Computed Tomographic Features and Kirsten Rat Sarcoma Viral Oncogene Mutations in Patients With Stage I Lung Adenocarcinoma and Their Prognostic Value.

Wang H, Schabath MB, Liu Y, Stringfield O, Balagurunathan Y, Heine JJ, Eschrich SA, Ye Z, Gillies RJ.

Clin Lung Cancer. 2016 Jul;17(4):271-8. doi: 10.1016/j.cllc.2015.11.002. Epub 2015 Nov 12.

13.

Impact of Concurrent PIK3CA Mutations on Response to EGFR Tyrosine Kinase Inhibition in EGFR-Mutant Lung Cancers and on Prognosis in Oncogene-Driven Lung Adenocarcinomas.

Eng J, Woo KM, Sima CS, Plodkowski A, Hellmann MD, Chaft JE, Kris MG, Arcila ME, Ladanyi M, Drilon A.

J Thorac Oncol. 2015 Dec;10(12):1713-9. doi: 10.1097/JTO.0000000000000671.

14.

Cytomorphologic features of advanced lung adenocarcinomas tested for EGFR and KRAS mutations: a retrospective review of 50 cases.

Marotti JD, Schwab MC, McNulty NJ, Rigas JR, DeLong PA, Memoli VA, Tsongalis GJ, Padmanabhan V.

Diagn Cytopathol. 2013 Jan;41(1):15-21. doi: 10.1002/dc.21749. Epub 2011 Jun 16.

PMID:
21681971
15.

Correlation between EGFR mutation status and computed tomography features in patients with advanced pulmonary adenocarcinoma.

Hsu JS, Huang MS, Chen CY, Liu GC, Liu TC, Chong IW, Chou SH, Yang CJ.

J Thorac Imaging. 2014 Nov;29(6):357-63. doi: 10.1097/RTI.0000000000000116.

PMID:
25303964
16.

Spectrum of oncogenic driver mutations in lung adenocarcinomas from East Asian never smokers.

Li C, Fang R, Sun Y, Han X, Li F, Gao B, Iafrate AJ, Liu XY, Pao W, Chen H, Ji H.

PLoS One. 2011;6(11):e28204. doi: 10.1371/journal.pone.0028204. Epub 2011 Nov 30.

17.

Radiomic Features Are Associated With EGFR Mutation Status in Lung Adenocarcinomas.

Liu Y, Kim J, Balagurunathan Y, Li Q, Garcia AL, Stringfield O, Ye Z, Gillies RJ.

Clin Lung Cancer. 2016 Sep;17(5):441-448.e6. doi: 10.1016/j.cllc.2016.02.001. Epub 2016 Feb 16.

18.

Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium.

Villaruz LC, Socinski MA, Abberbock S, Berry LD, Johnson BE, Kwiatkowski DJ, Iafrate AJ, Varella-Garcia M, Franklin WA, Camidge DR, Sequist LV, Haura EB, Ladanyi M, Kurland BF, Kugler K, Minna JD, Bunn PA, Kris MG.

Cancer. 2015 Feb 1;121(3):448-56. doi: 10.1002/cncr.29042. Epub 2014 Oct 1.

19.

Frequency of driver mutations in lung adenocarcinoma from female never-smokers varies with histologic subtypes and age at diagnosis.

Zhang Y, Sun Y, Pan Y, Li C, Shen L, Li Y, Luo X, Ye T, Wang R, Hu H, Li H, Wang L, Pao W, Chen H.

Clin Cancer Res. 2012 Apr 1;18(7):1947-53. doi: 10.1158/1078-0432.CCR-11-2511. Epub 2012 Feb 8.

20.

Radiogenomic evaluation of lung cancer - Are there imaging characteristics associated with lung adenocarcinomas harboring BRAF mutations?

Halpenny DF, Plodkowski A, Riely G, Zheng J, Litvak A, Moscowitz C, Ginsberg MS.

Clin Imaging. 2017 Mar - Apr;42:147-151. doi: 10.1016/j.clinimag.2016.11.015. Epub 2016 Nov 30.

Supplemental Content

Support Center